Vaccine News and Research

Latest Vaccine News and Research

Nuclera joins Tech Nation’s Future Fifty program

Nuclera recognized as one of UK’s most exciting growth stage companies.

From Nuclera 20 Mar 2024

Needle pain is a big problem for kids. One California doctor has a plan.

Almost all new parents go through it: the distress of hearing their child scream at the doctor's office.

20 Mar 2024

Ownership-based text messages boost COVID booster uptake

New research published in Nature Human Behavior suggests that text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster.

18 Mar 2024

Study reveals why COVID-19 antibodies fade quickly

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the antibody response following SARS-CoV-2 infection.

18 Mar 2024

COVID-19 vaccine associated with reduced risk of cardiac and clot-related complications after SARS-CoV-2 infection

The risk of cardiac and clot-related complications following COVID-19 is substantially reduced in people who receive the COVID-19 vaccination compared with unvaccinated individuals, reports an observational study published online in the journal Heart.

18 Mar 2024

Synthetic mucins shed light on cancer biology and tumor formation

During cold and flu season, excess mucus is a common, unpleasant symptom of illness, but the slippery substance is essential to human health.

18 Mar 2024

Viroclinics-DDL rebrands to Cerba Research

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands) a world leading vaccine and antiviral specialty laboratory providing research and clinical trial solutions rooted in virology, proudly announces changing its name to Cerba Research as of the 1st of April 2024.

18 Mar 2024

Measles outbreak in Illinois underscores critical need for vaccination

Study reports a measles outbreak among five unvaccinated children in Illinois, highlighting the disease's high transmissibility even among those not in direct contact, underscoring the critical importance of vaccination.

17 Mar 2024

CHOP study uncovers metabolic key to faster immune response

Researchers from Children's Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.

15 Mar 2024

Future drug makers can develop their skills using virtual reality at new national Centre of Excellence

Future medicine and vaccine makers will be able to develop their skills using virtual reality at a new national Centre of Excellence, after a successful funding bid involving UCL.

15 Mar 2024

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

Therapeutic cancer vaccines are a form of immunotherapy in the making that could not only destroy cancer cells in patients, but keep a cancer from coming back and spreading.

15 Mar 2024

Study highlights growing burden of neurological disorders worldwide

Globally, the number of people living with, or dying from, neurological conditions such as stroke, Alzheimer's disease and other dementias, and meningitis has risen substantially over the past 30 years due to the growth and aging of the global population as well as increased exposure to environmental, metabolic, and lifestyle risk factors.

15 Mar 2024

Innovative approaches needed to overcome health system barriers in malaria vaccination

The current literature to investigate the challenges malaria vaccination faced in reaching high-risk children.

15 Mar 2024

Rapid COVID-19 vaccine uptake in Sierra Leone: Impact of intensive delivery initiative

Sierra Leone's COVID-19 vaccination program, using community mobilization in remote villages, dramatically increased vaccine uptake, showing a scalable, cost-effective model for improving global vaccine access.

14 Mar 2024

Viral infections contribute to more cases of intussusception in kids

Viral infections trigger more cases of intussusception, the common cause of bowel blockages in young children, than previously thought, according to a new study.

14 Mar 2024

Rapid, easy-to-use diagnostic test could save more lives from melioidosis

Globally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before they are diagnosed.

13 Mar 2024

Study reveals decline in cancer mortality among middle-aged people in the UK

A study by Cancer Research UK has revealed that fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years.

13 Mar 2024

New collaboration launched to support the development of vaccines against henipavirus

A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against henipavirus - a genus (or group) of viruses including Nipah virus.

13 Mar 2024

Study highlights impact of government vaccine recommendations and direct-to-consumer pharmaceutical advertising

A new study co-authored by a University of Massachusetts Amherst economist reveals the value of government vaccine recommendations to drugmakers, as well as potential benefits of advertising pharmaceuticals directly to consumers -; a practice that is banned in every country apart from the United States and New Zealand.

13 Mar 2024